Elamparithi Jayamani

This inventor holds 9 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: The General Hospital Corporation, Marvelbiome, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elamparithi Jayamani. Retrieved from https://idiyas.com/inventor/elamparithi-jayamani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Malden, MA (US) (2021 - 2022)
Boston, MA (US) (2021 - 2023)
Melrose, MA (US) (2024)

Company Filing History:

5 out of 3,076

The General Hospital Corporation

Years Active: 2021-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649942 - CAROTENOIDS FOR TREATING OR PREVENTING NAUSEA (2026-06-09),

2. 12553883 - Methods and uses of microbiome compositions (2026-02-17),

3. 12285446 - Compositions and methods for improving mitochondrial function (2025-04-29),

4. 11957723 - Methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases (2024-04-16),

5. 11738056 - Compositions and methods for improving mitochondrial function (2023-08-29),

6. 11284609 - Compositions and methods for characterizing a microbiome (2022-03-29),

7. 11122828 - Microbial compositions comprising ellagitannin and methods of use (2021-09-21),

8. 11001870 - Carotenoids for treating or preventing nausea (2021-05-11),

9. 10973860 - Compositions and methods for improving mitochondrial function (2021-04-13),

Title: Elamparithi Jayamani: Innovator in Mitochondrial Function and Neurodegenerative Disease Treatment

Introduction

Elamparithi Jayamani is a notable inventor based in Malden, MA (US), recognized for his contributions to the fields of mitochondrial function and neurodegenerative disease treatment. With a total of seven patents to his name, he has made significant strides in enhancing our understanding of these critical areas of health.

Latest Patents

Among his latest patents, Jayamani has developed compositions and methods for improving mitochondrial function. These innovations include methods and compositions that utilize a bacterium or its metabolites to enhance mitochondrial and peroxisomal function. Additionally, he has created methods and uses of microbiome compositions, components, or metabolites for treating neurodegenerative diseases. This work involves compositions that may comprise one or more microbial strains, components, or metabolites aimed at addressing various neurodegenerative disorders.

Career Highlights

Throughout his career, Jayamani has worked with esteemed organizations such as The General Hospital Corporation and Marvelbiome, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jothi Amaranath Govindan and Gary B Ruvkun. Their collaborative efforts have further advanced the research and development of innovative solutions in their respective fields.

Conclusion

Elamparithi Jayamani's work exemplifies the impact of innovation in healthcare, particularly in mitochondrial function and neurodegenerative disease treatment. His patents and collaborations highlight his commitment to advancing scientific knowledge and improving patient outcomes.

Profile summary based on public USPTO records.